Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1964 1
1965 4
1966 1
1967 2
1969 2
1970 3
1971 4
1972 5
1973 9
1974 4
1975 5
1976 4
1977 7
1978 14
1979 15
1980 3
1981 8
1982 8
1983 11
1984 19
1985 19
1986 11
1987 14
1988 14
1989 6
1990 13
1991 6
1992 7
1993 14
1994 13
1995 19
1996 11
1997 7
1998 5
1999 22
2000 7
2001 9
2002 8
2003 13
2004 14
2005 8
2006 11
2007 16
2008 9
2009 12
2010 16
2011 14
2012 15
2013 13
2014 10
2015 16
2016 15
2017 31
2018 22
2019 17
2020 16
2021 25
2022 27
2023 17
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

640 results

Results by year

Filters applied: . Clear all
Page 1
[Preface].
Miyamoto L, Okuyama S. Miyamoto L, et al. Among authors: okuyama s. Nihon Yakurigaku Zasshi. 2020;155(4):201. doi: 10.1254/fpj20026. Nihon Yakurigaku Zasshi. 2020. PMID: 32612028 Japanese. No abstract available.
Near-infrared photoimmunotherapy (NIR-PIT) of bone metastases.
Inagaki FF, Wakiyama H, Furusawa A, Okada R, Kato T, Fujimura D, Okuyama S, Fukushima H, Takao S, Choyke PL, Kobayashi H. Inagaki FF, et al. Among authors: okuyama s. Biomed Pharmacother. 2023 Apr;160:114390. doi: 10.1016/j.biopha.2023.114390. Epub 2023 Feb 13. Biomed Pharmacother. 2023. PMID: 36791566 Free article.
Intratumoral IL15 Improves Efficacy of Near-Infrared Photoimmunotherapy.
Fukushima H, Furusawa A, Kato T, Wakiyama H, Takao S, Okuyama S, Choyke PL, Kobayashi H. Fukushima H, et al. Among authors: okuyama s. Mol Cancer Ther. 2023 Oct 2;22(10):1215-1227. doi: 10.1158/1535-7163.MCT-23-0210. Mol Cancer Ther. 2023. PMID: 37461129
Near-infrared photoimmunotherapy through bone.
Nakamura YA, Okuyama S, Furusawa A, Nagaya T, Fujimura D, Okada R, Maruoka Y, Eclarinal PC, Choyke PL, Kobayashi H. Nakamura YA, et al. Among authors: okuyama s. Cancer Sci. 2019 Dec;110(12):3689-3694. doi: 10.1111/cas.14203. Epub 2019 Oct 22. Cancer Sci. 2019. PMID: 31553485 Free PMC article.
[Idiosyncratic drug toxicity].
Yamada H, Yamaguchi J, Iida I, Okuyama S. Yamada H, et al. Among authors: okuyama s. Nihon Yakurigaku Zasshi. 2006 Jun;127(6):473-80. doi: 10.1254/fpj.127.473. Nihon Yakurigaku Zasshi. 2006. PMID: 16880698 Review. Japanese. No abstract available.
Cerenkov Radiation-Induced Photoimmunotherapy with 18F-FDG.
Nakamura Y, Nagaya T, Sato K, Okuyama S, Ogata F, Wong K, Adler S, Choyke PL, Kobayashi H. Nakamura Y, et al. Among authors: okuyama s. J Nucl Med. 2017 Sep;58(9):1395-1400. doi: 10.2967/jnumed.116.188789. Epub 2017 Apr 13. J Nucl Med. 2017. PMID: 28408528 Free PMC article.
Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy.
Furumoto H, Okada R, Kato T, Wakiyama H, Inagaki F, Fukushima H, Okuyama S, Furusawa A, Choyke PL, Kobayashi H. Furumoto H, et al. Among authors: okuyama s. Cancers (Basel). 2022 Aug 22;14(16):4042. doi: 10.3390/cancers14164042. Cancers (Basel). 2022. PMID: 36011036 Free PMC article.
640 results